Although plant cell-based bioproduction has advanced considerably during the past several years, certain elements remain largely unexplored.

LEWES, Del., Feb. 26, 2025 /PRNewswire/ -- The Global CRISPR Market Size is projected to grow at a CAGR of 15.85% from 2026 to 2032, according to a new report published by Verified Market Research®.

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Wugen, Inc., a clinical-stage U.S. biotechnology company developing allogeneic, off-the-shelf cell therapies for the ...

ERS Genomics ('ERS'), which was established to provide broad access to the foundational CRISPR/Cas9 intellectual property ...

为解决血友病 B 治疗难题，韩国研究人员开展 iPSC 源工程肝细胞片治疗血友病 B 的研究。结果显示该细胞片能长时间分泌 FIX 蛋白。这一成果为血友病 B 治疗带来新希望，极具科研价值，推荐大家阅读。

Genetic technologies have the potential to help solve the ever-growing challenges of food insecurity and global health. But for this potential to be met, regulations that hinder scientific innovation ...

YolTech Therapeutics, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, today reported positive results from ...

Inherited retinal dystrophies (IRDs), including retinitis pigmentosa and Stargardt disease, are a group of rare degenerative disorders of the retina with clinical and genetic heterogeneity. In a ...

Scientists are exploring gene editing as a way to correct trisomy at the cellular level. Using CRISPR-Cas9, researchers ...

为解决血友病 B 治疗难题，韩国加图立大学研究人员开展用工程化 FIX 分泌肝细胞片治疗血友病 B 的研究。结果显示该细胞片能长效分泌 FIX，意义重大。这一成果极具价值，推荐科研读者阅读。